Search the Newsreel

Indivior Q2 2026 slides: SUBLOCADE drives 111% EBITDA surge

Indivior PLC reported strong Q2 2026 financial results, with adjusted EBITDA surging 111% driven by its opioid use disorder treatment, SUBLOCADE. Despite exceeding analyst expectations, the company's stock experienced a slight decline, likely due to investor caution regarding its proposed merger with Supernus Pharmaceuticals. …

Indivior Q2 Earnings Call Highlights

Indivior and Supernus Pharmaceuticals announced an all-stock merger of equals, expected to close in Q4 2026, creating a CNS-focused biopharmaceutical company with approximately $2.2 billion in pro forma trailing-12-month net revenue. The combined entity will retain the Supernus name and be led by Supernus …

Inovio proposes underwritten public offering of common stock, warrants

Inovio has initiated an underwritten public offering of common stock and accompanying warrants, or pre-funded warrants in lieu of common stock. Piper Sandler is the sole manager for this offering, which includes a 30-day option for underwriters to purchase up to an additional 15% …

Indivior PLC Lobbyists, 2023

This article from OpenSecrets details Indivior PLC's lobbying activities and lobbyists for the year 2023. It identifies 19 named lobbyists, with 15 (78.9%) having a "revolving door" background, meaning prior federal government employment. The report breaks down lobbyists by hiring firm, including Williams & …

Red Violet, Inc. Revenue Breakdown – NASDAQ:RDVT

Red Violet, Inc. (NASDAQ:RDVT) generated $90.30 million USD in revenue last year, primarily from its Artificial Intelligence-enabled Identity Intelligence Platform segment, which contributed $90.25 million USD. The vast majority of this revenue, $90.25 million USD, originated from operations within the United States. This marks …

Navios Maritime Partners (NYSE:NMM) Insider Acquires 1,051 Shares of Stock

Navios Maritime Partners (NYSE:NMM) insider Angeliki Frangou recently purchased 1,051 shares of the company's stock for over $82,000, increasing her total holdings to 4.78 million shares. This is one of multiple purchases by Frangou in July. The company reported strong Q1 earnings, beating estimates …

Navios Maritime Partners (NYSE:NMM) Insider Purchases $84,248.48 in Stock

Navios Maritime Partners (NYSE:NMM) insider Angeliki Frangou recently purchased 1,072 shares valued at $84,248.48, increasing her total holdings to over 4.7 million shares. This is part of a series of purchases made by Frangou in July. The company has shown strong performance with its …

Price to sales forward of Navios Maritime Partners LP – NYSE:NMM

This article provides financial data for Navios Maritime Partners LP (NYSE: NMM), specifically focusing on its forward price-to-sales ratio. It presents a value for this metric for a given period and highlights that the information is made by humans. The content is presented within …

Price-Driven Insight from (NMM) for Rule-Based Strategy

This article provides a price-driven insight for Navios Maritime Partners Lp (NYSE: NMM) for a rule-based strategy. It highlights strong sentiment across all horizons supporting an overweight bias, an exceptional risk-reward setup targeting an 8.3% gain, and offers three distinct trading strategies: Position Trading, …

Artivion Number of Employees 2026 | Employee Count & Headcount Data

Artivion, Inc. (AORT) had 1,828 employees worldwide as of March 2026, representing a 14.8% growth since 2023. The company is actively hiring with 107 job postings in 2026, and its workforce is primarily concentrated in North America (51.1%). The average salary at Artivion is …

Vanguard Capital Management (INO) discloses 5.05% beneficial stake in Inovio stock

Vanguard Capital Management has disclosed a 5.05% beneficial stake in Inovio Pharmaceuticals Inc. (INO), totaling 4,161,566 shares, as reported in a Schedule 13G SEC filing. Vanguard holds sole voting power over 511,004 shares and sole dispositive power over all 4,161,566 shares. This filing indicates …

Press Release: Navios Maritime Partners L.P. Announces Cash Distribution of $0.06 per Unit

Navios Maritime Partners L.P. announced a cash distribution of $0.06 per common unit for the second quarter of 2024. This distribution is payable on August 13, 2024, to unitholders of record as of August 9, 2024. The announcement was made by the Board of …

Viomi Technology Co., Ltd. Sponsored ADR (NASDAQ:VIOT) Short Interest Update

Short interest in Viomi Technology Co., Ltd. Sponsored ADR (NASDAQ:VIOT) increased by 64.5% to 276,850 shares as of July 15th, representing 0.6% of the company's outstanding stock. The stock opened at $0.76, near its 52-week low, and analysts have a consensus "Sell" rating. Despite …

Inovio Pharmaceuticals Secures $18.3 Million Stock-and-Warrant Offering With Piper Sandler

Inovio Pharmaceuticals has entered an underwriting agreement with Piper Sandler for a public offering valued at approximately $18.3 million. The offering includes 21,052,632 shares of common stock and warrants to purchase up to 42,105,264 additional shares, priced at $0.95 per share and warrant. The …

Red Violet Inc (RDVT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Red Violet Inc (RDVT), detailing its current price momentum score, support and resistance levels, and various technical indicators. It also includes an analysis of moving averages and a FAQ section explaining common technical analysis terms. The analysis …

Navios Maritime Partners (NYSE:NMM) Hits New 1-Year High Following Dividend Announcement

Indivior PLC (INDV) Financial Health: Profitability & Balance Sheet Analysis

Indivior PLC (INDV) has a current financial score of 7.94, ranking 87th out of 155 in the Pharmaceuticals industry, indicating a weak financial status despite high operating efficiency. The company reported a 19.17% year-over-year increase in quarterly revenue to $317.00 million and a 93.48% …

Form 4 Navios Maritime Partners L.P. For: 30 July By Investing.com

This article announces the filing of Form 4 for Navios Maritime Partners L.P. on July 30. It is a brief, news-style announcement often found on financial market websites, indicating a regulatory filing has occurred. The content provided is minimal, focusing solely on the announcement …

Navios Partners (NYSE: NMM) CEO adds 3,191 units under 10b5-1 plan

Navios Maritime Partners L.P. CEO Angeliki Frangou, through an affiliated entity, purchased 3,191 common units in open-market transactions between July 28-30, 2026, under a Rule 10b5-1 trading plan. The purchases were made at weighted average prices ranging from $78.3705 to $78.5875 per unit. Frangou …

Form 424B5 Inovio Pharmaceuticals Inc For: 30 July By Investing.com

The article reports on the filing of Form 424B5 by Inovio Pharmaceuticals Inc. on July 30th. It is a brief update from Investing.com, likely concerning a securities registration or prospectus related to the company. The article also provides various market data unrelated to Inovio …

$0.06 Unit Payment Is Due Aug. 13 – Navios Maritime Partners (NYSE:NMM)

Navios Maritime Partners (NYSE:NMM) announced a quarterly cash distribution of $0.06 per unit for the quarter ended June 30, 2026, corresponding to an annualized distribution of $0.24 per unit. This payment is scheduled for August 13, 2026, to unitholders of record as of August …

Viohalco (ENXTBR:VIO) Stock Price Meets Margin Resilience And Revenue Drop

Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors

Inovio Pharmaceuticals Inc. (INO) stock dropped significantly by 36.92% on Thursday, closing at $0.66. This underperformance occurred despite a positive trading session for the broader market, with the NASDAQ Composite Index and Dow Jones Industrial Average both showing gains. The stock's decline ended a …

Inovio raises USD 20m ahead of make-or-break FDA decision on INO-3107

Inovio Pharmaceuticals has raised $20 million through an underwritten public offering as it anticipates a crucial FDA decision on its lead asset, INO-3107. The financing, which included shares and warrants, comes amidst a declining stock price and aims to extend the company's cash runway …

Navios Maritime Partners (NMM) Stock Still Looks Undervalued On Earnings Power

Navios Maritime Partners (NMM) has shown strong long-term returns, yet its stock appears undervalued based on current earnings power and various valuation metrics. The company trades at a P/E ratio significantly lower than its industry average and fair value model, suggesting the market might …

AUMOVIO und BMW erzielen Vergleich zur einvernehmlichen Erledigung rechtlicher Auseinandersetzungen; Anpassung der Prognose

Indivior Number of Employees 2026 | Employee Count & Headcount Data

Indivior Ltd. has an estimated 1,015 employees worldwide as of March 2026, marking a 25.4% decline in headcount since 2023. The Pharmaceuticals company, headquartered in Bon Air, Virginia, is actively hiring with 50 job postings in 2026, though this represents a 5.8% decline from …

Avio Smart Market Stack signs MoU with ProClima for biochar soil tech

Marico, JK Tyre, IG Petrochemicals, Kokuyo Camlin, Cheviot Dividend Record Date: Last Day To Buy Shares To Qualify

Artivion (AORT) Projected to Post Earnings on Thursday

Inovio announces proposed public offering of stock and warrants By Investing.com

INOVIO Pharmaceuticals Inc. announced its plan for an underwritten public offering of common stock and accompanying warrants. The company will also grant the underwriter a 30-day option to purchase additional shares and warrants. The offering is subject to market conditions and there is no …

Inovio Offering Expected to Close Around July 31 >INO

The article states that Inovio's offering is anticipated to close around July 31.

INOVIO Announces Pricing of $20.0 Million Public Offering

INOVIO Pharmaceuticals, Inc. announced the pricing of a public offering for $20.0 million, consisting of common stock and accompanying warrants. The offering includes 21,052,632 shares of common stock and warrants to purchase up to 42,105,264 shares, priced at $0.95 per share and warrant. The …

INOVIO Pharmaceuticals Prices Public Offering of Common Stock

INOVIO Pharmaceuticals announced the pricing of a public offering of 21,052,632 shares of common stock and accompanying warrants at $0.95 per share, aiming to raise approximately $20 million. Piper Sandler is the sole manager for the offering, which includes an option for the underwriter …

INOVIO Plans Stock and Warrant Sale, Size and Terms Unclear

INOVIO announced its intention to conduct an underwritten public offering of common stock and accompanying warrants or pre-funded warrants. The proposed offering is subject to market conditions, and its completion, actual size, or terms are not yet assured, with Piper Sandler acting as the …

Red Violet (NASDAQ:RDVT) Hits New 52-Week High - Here's What Happened

Red Violet (NASDAQ:RDVT) reached a new 52-week high of $69.82, driven by strong quarterly results that surpassed analyst expectations with an EPS of $0.46 and revenue of $25.83 million. Despite a "Moderate Buy" consensus rating, the average price target is $62.00, and insiders have …